[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Renal Replacement and End Stage Renal Disease Therapy Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: R898FD3B4395EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Renal replacement therapy (RRT) is therapy that replaces the normal blood-filtering function of the kidneys. It is used when the kidneys are not working well, which is called kidney failure and includes acute kidney injury and chronic kidney disease. Renal replacement therapy includes dialysis (hemodialysis or peritoneal dialysis), hemofiltration, and hemodiafiltration, which are various ways of filtration of blood with or without machines. Renal replacement therapy also includes kidney transplantation, which is the ultimate form of replacement in that the old kidney is replaced by a donor kidney.

This report contains market size and forecasts of Renal Replacement and End Stage Renal Disease Therapy in Global, including the following market information:

Global Renal Replacement and End Stage Renal Disease Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Renal Replacement and End Stage Renal Disease Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Renal Replacement and End Stage Renal Disease Therapy include Fresenius, DaVita, Baxter, US rental care, B.Braun, Diaverum, Nipro, Asahi Kasei and Nikkiso, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Renal Replacement and End Stage Renal Disease Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Renal Replacement and End Stage Renal Disease Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Renal Replacement and End Stage Renal Disease Therapy Market Segment Percentages, by Type, 2021 (%)
  • Devices
  • Consumables
  • Services
Global Renal Replacement and End Stage Renal Disease Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Renal Replacement and End Stage Renal Disease Therapy Market Segment Percentages, by Application, 2021 (%)
  • Hospital
  • Dialysis Center
  • Other
Global Renal Replacement and End Stage Renal Disease Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Renal Replacement and End Stage Renal Disease Therapy Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Renal Replacement and End Stage Renal Disease Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Renal Replacement and End Stage Renal Disease Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Fresenius
  • DaVita
  • Baxter
  • US rental care
  • B.Braun
  • Diaverum
  • Nipro
  • Asahi Kasei
  • Nikkiso
  • Toray
  • WEGO
  • JMS
  • Medtronic
  • SWS Hemodialysis Care
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Renal Replacement and End Stage Renal Disease Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Renal Replacement and End Stage Renal Disease Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RENAL REPLACEMENT AND END STAGE RENAL DISEASE THERAPY OVERALL MARKET SIZE

2.1 Global Renal Replacement and End Stage Renal Disease Therapy Market Size: 2021 VS 2028
2.2 Global Renal Replacement and End Stage Renal Disease Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Renal Replacement and End Stage Renal Disease Therapy Players in Global Market
3.2 Top Global Renal Replacement and End Stage Renal Disease Therapy Companies Ranked by Revenue
3.3 Global Renal Replacement and End Stage Renal Disease Therapy Revenue by Companies
3.4 Top 3 and Top 5 Renal Replacement and End Stage Renal Disease Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Renal Replacement and End Stage Renal Disease Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Renal Replacement and End Stage Renal Disease Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Renal Replacement and End Stage Renal Disease Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Renal Replacement and End Stage Renal Disease Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Renal Replacement and End Stage Renal Disease Therapy Market Size Markets, 2021 & 2028
  4.1.2 Devices
  4.1.3 Consumables
  4.1.4 Services
4.2 By Type - Global Renal Replacement and End Stage Renal Disease Therapy Revenue & Forecasts
  4.2.1 By Type - Global Renal Replacement and End Stage Renal Disease Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Renal Replacement and End Stage Renal Disease Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Renal Replacement and End Stage Renal Disease Therapy Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Dialysis Center
  5.1.4 Other
5.2 By Application - Global Renal Replacement and End Stage Renal Disease Therapy Revenue & Forecasts
  5.2.1 By Application - Global Renal Replacement and End Stage Renal Disease Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Renal Replacement and End Stage Renal Disease Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Renal Replacement and End Stage Renal Disease Therapy Market Size, 2021 & 2028
6.2 By Region - Global Renal Replacement and End Stage Renal Disease Therapy Revenue & Forecasts
  6.2.1 By Region - Global Renal Replacement and End Stage Renal Disease Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Renal Replacement and End Stage Renal Disease Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Renal Replacement and End Stage Renal Disease Therapy Revenue, 2017-2028
  6.3.2 US Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.3.3 Canada Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.3.4 Mexico Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Renal Replacement and End Stage Renal Disease Therapy Revenue, 2017-2028
  6.4.2 Germany Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.4.3 France Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.4.4 U.K. Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.4.5 Italy Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.4.6 Russia Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.4.8 Benelux Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Renal Replacement and End Stage Renal Disease Therapy Revenue, 2017-2028
  6.5.2 China Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.5.3 Japan Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.5.4 South Korea Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.5.6 India Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Renal Replacement and End Stage Renal Disease Therapy Revenue, 2017-2028
  6.6.2 Brazil Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.6.3 Argentina Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Revenue, 2017-2028
  6.7.2 Turkey Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.7.3 Israel Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028
  6.7.5 UAE Renal Replacement and End Stage Renal Disease Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Fresenius
  7.1.1 Fresenius Corporate Summary
  7.1.2 Fresenius Business Overview
  7.1.3 Fresenius Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.1.4 Fresenius Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.1.5 Fresenius Key News
7.2 DaVita
  7.2.1 DaVita Corporate Summary
  7.2.2 DaVita Business Overview
  7.2.3 DaVita Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.2.4 DaVita Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.2.5 DaVita Key News
7.3 Baxter
  7.3.1 Baxter Corporate Summary
  7.3.2 Baxter Business Overview
  7.3.3 Baxter Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.3.4 Baxter Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.3.5 Baxter Key News
7.4 US rental care
  7.4.1 US rental care Corporate Summary
  7.4.2 US rental care Business Overview
  7.4.3 US rental care Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.4.4 US rental care Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.4.5 US rental care Key News
7.5 B.Braun
  7.5.1 B.Braun Corporate Summary
  7.5.2 B.Braun Business Overview
  7.5.3 B.Braun Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.5.4 B.Braun Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.5.5 B.Braun Key News
7.6 Diaverum
  7.6.1 Diaverum Corporate Summary
  7.6.2 Diaverum Business Overview
  7.6.3 Diaverum Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.6.4 Diaverum Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.6.5 Diaverum Key News
7.7 Nipro
  7.7.1 Nipro Corporate Summary
  7.7.2 Nipro Business Overview
  7.7.3 Nipro Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.7.4 Nipro Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.7.5 Nipro Key News
7.8 Asahi Kasei
  7.8.1 Asahi Kasei Corporate Summary
  7.8.2 Asahi Kasei Business Overview
  7.8.3 Asahi Kasei Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.8.4 Asahi Kasei Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.8.5 Asahi Kasei Key News
7.9 Nikkiso
  7.9.1 Nikkiso Corporate Summary
  7.9.2 Nikkiso Business Overview
  7.9.3 Nikkiso Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.9.4 Nikkiso Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.9.5 Nikkiso Key News
7.10 Toray
  7.10.1 Toray Corporate Summary
  7.10.2 Toray Business Overview
  7.10.3 Toray Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.10.4 Toray Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.10.5 Toray Key News
7.11 WEGO
  7.11.1 WEGO Corporate Summary
  7.11.2 WEGO Business Overview
  7.11.3 WEGO Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.11.4 WEGO Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.11.5 WEGO Key News
7.12 JMS
  7.12.1 JMS Corporate Summary
  7.12.2 JMS Business Overview
  7.12.3 JMS Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.12.4 JMS Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.12.5 JMS Key News
7.13 Medtronic
  7.13.1 Medtronic Corporate Summary
  7.13.2 Medtronic Business Overview
  7.13.3 Medtronic Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.13.4 Medtronic Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.13.5 Medtronic Key News
7.14 SWS Hemodialysis Care
  7.14.1 SWS Hemodialysis Care Corporate Summary
  7.14.2 SWS Hemodialysis Care Business Overview
  7.14.3 SWS Hemodialysis Care Renal Replacement and End Stage Renal Disease Therapy Major Product Offerings
  7.14.4 SWS Hemodialysis Care Renal Replacement and End Stage Renal Disease Therapy Revenue in Global Market (2017-2022)
  7.14.5 SWS Hemodialysis Care Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Renal Replacement and End Stage Renal Disease Therapy Market Opportunities & Trends in Global Market
Table 2. Renal Replacement and End Stage Renal Disease Therapy Market Drivers in Global Market
Table 3. Renal Replacement and End Stage Renal Disease Therapy Market Restraints in Global Market
Table 4. Key Players of Renal Replacement and End Stage Renal Disease Therapy in Global Market
Table 5. Top Renal Replacement and End Stage Renal Disease Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Renal Replacement and End Stage Renal Disease Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Renal Replacement and End Stage Renal Disease Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Renal Replacement and End Stage Renal Disease Therapy Product Type
Table 9. List of Global Tier 1 Renal Replacement and End Stage Renal Disease Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Renal Replacement and End Stage Renal Disease Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Renal Replacement and End Stage Renal Disease Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Renal Replacement and End Stage Renal Disease Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Renal Replacement and End Stage Renal Disease Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Renal Replacement and End Stage Renal Disease Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Fresenius Corporate Summary
Table 31. Fresenius Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 32. Fresenius Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 33. DaVita Corporate Summary
Table 34. DaVita Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 35. DaVita Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Baxter Corporate Summary
Table 37. Baxter Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 38. Baxter Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 39. US rental care Corporate Summary
Table 40. US rental care Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 41. US rental care Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 42. B.Braun Corporate Summary
Table 43. B.Braun Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 44. B.Braun Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Diaverum Corporate Summary
Table 46. Diaverum Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 47. Diaverum Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Nipro Corporate Summary
Table 49. Nipro Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 50. Nipro Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Asahi Kasei Corporate Summary
Table 52. Asahi Kasei Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 53. Asahi Kasei Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Nikkiso Corporate Summary
Table 55. Nikkiso Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 56. Nikkiso Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Toray Corporate Summary
Table 58. Toray Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 59. Toray Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 60. WEGO Corporate Summary
Table 61. WEGO Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 62. WEGO Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 63. JMS Corporate Summary
Table 64. JMS Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 65. JMS Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 66. Medtronic Corporate Summary
Table 67. Medtronic Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 68. Medtronic Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 69. SWS Hemodialysis Care Corporate Summary
Table 70. SWS Hemodialysis Care Renal Replacement and End Stage Renal Disease Therapy Product Offerings
Table 71. SWS Hemodialysis Care Renal Replacement and End Stage Renal Disease Therapy Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Renal Replacement and End Stage Renal Disease Therapy Segment by Type in 2021
Figure 2. Renal Replacement and End Stage Renal Disease Therapy Segment by Application in 2021
Figure 3. Global Renal Replacement and End Stage Renal Disease Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Renal Replacement and End Stage Renal Disease Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Renal Replacement and End Stage Renal Disease Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Renal Replacement and End Stage Renal Disease Therapy Revenue in 2021
Figure 8. By Type - Global Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share, 2017-2028
Figure 12. US Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share, 2017-2028
Figure 24. China Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Renal Replacement and End Stage Renal Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Fresenius Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. DaVita Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Baxter Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. US rental care Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. B.Braun Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Diaverum Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Nipro Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Asahi Kasei Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Nikkiso Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Toray Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. WEGO Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. JMS Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Medtronic Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. SWS Hemodialysis Care Renal Replacement and End Stage Renal Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications